Afuco™ Anti-Human FZD2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FZD2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody specifically bind Fzd2, and may promote internalization of the Fzd2 receptor by the cancer cells and/or prevent ligand binding to Fzd2. It is used for treatment of specific cancers such as late stage hepatocellular carcinoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-283CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | FZD2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4 °C, -20°C if preferred |